Peripheral Neuropathy Complicates Treatment of Hematologic Malignancies
Treatment regimens including immunomodulatory agents or proteasome inhibitors could lead to development of peripheral neuropathy.
General Hematology
Clinical Biomarkers May Assist in Management of Persistent Chronic Graft-Versus-Host Disease
Symptom burden may be higher in patients with persistent cGVHD compared with patients with recently diagnosed cGVHD.
Hematologic Abnormalities in Patients With Eating Disorders
Researchers assessed the incidence of various hematologic disorders in patients with bulimia nervosa and anorexia nervosa.
Clonal Mutations in Donors May Show Expansion in Recipients After HSCT
Of clonal mutations found in donors, 84.2% were predicted to be molecularly pathogenic and 100% engrafted in recipients.
Personalizing Intensive Therapy for Older Patients With Hematologic Cancers
Several factors need to be considered when choosing optimal therapy for older patients with hematologic malignancies, particularly when it comes to managing toxicity.
Low-Dose Aspirin in Children With Kawasaki Disease
For children with Kawasaki disease (KD), the use of low-dose aspirin, rather than high-dose aspirin, may not increase risk for recrudescent fever when given in combination with intravenous immunoglobulin (IVIG), according to study results published in JAMA Network Open. The study was a retrospective cohort analysis that included 260 patients with KD who were treated…
Why Do Patients With Myelofibrosis Discontinue Ruxolitinib?
Researchers assessed how the reasons that led to discontinuation of ruxolitinib influenced survival in patients with myelofibrosis.
Haymarket Medical Education Receives Interprofessional Joint Accreditation for the Healthcare Team
Caroline O. Pardo, Ph.D., General Manager for Haymarket Medical Education, is pleased to announce that HME, based in Paramus, NJ, has been accredited as a provider of interprofessional continuing education by the Accreditation Council for Continuing Medical Education, the Accreditation Council for Pharmacy Education, and the American Nursing Credentialing Center.
Novel Risk Factors Associated With Chronic Graft-Versus-Host Disease Severity
Researchers identified 3 risk factors that were associated with the development of moderate to severe chronic graft-versus-host disease.
Differences in the Perceived Chance of Cure Between Patients and Hematologists
Patient-hematologist discordance in perceived chance of cure appears to improve after a hematology consultation.
Next post in General Hematology
